Events & Presentations       Publications 

Publications

March 29, 2022, an article was published in the open access journal Cancers: "Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival" by V. Vuaroqueaux et al.

https://www.mdpi.com/2072-6694/14/7/1749

------------------------------------

October 28, 2021, an article in the nature partner journal Precision Oncology was published: "Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers" by V. Vuaroqueaux et al.

https://www.nature.com/articles/s41698-021-00235-7

------------------------------------

 

March 13, 2020, an article in the European Journal of Medicinal Chemistry was published: "A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia" by A. Sellmer et al.

https://doi.org/10.1016/j.ejmech.2020.112232